VTV THERAPEUTICS INC- CL A
VTVT · NASDAQ
Updated at 2026-10-14 09:17:16
- Today's High
- $31.21
- Today’s Low
- $27.87
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $31.12
- Previous Close
- $30.46
- Volume
- 17.12K
- Market Cap
- $120.43M
- P/E Ratio
- --
- EPS
- $-1.05
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3980 PREMIER DRIVE, HIGH POINT, NC, UNITED STATES, 27265
- Country
- US
- Listing Date
- 2015-07-30
- Fiscal Year End
- December
- Shares Outstanding
- 3.94M
- CIK
- 0001641489
- Website
- vtvtherapeutics.com
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet unmet medical needs.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$36.83M
2025-12-31
-$24K
2025-09-30
$0
Operating Expenses
2026-06-30
$13.93M
2026-03-31
$13.57M
2025-12-31
$7.88M
2025-09-30
$10.69M
Net Income
2026-06-30
-$13.05M
2026-03-31
$24.13M
2025-12-31
-$7.13M
2025-09-30
-$8.69M
Net Profit Margin
2026-06-30
--
2026-03-31
65.51%
2025-12-31
29.74K%
2025-09-30
--
Earnings Per Share
2026-06-30
$-1.05
2026-03-31
$1.65
2025-12-31
$-0.58
2025-09-30
$-1.08
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$13.05M
2026-03-31
$24.13M
2025-12-31
-$7.13M
2025-09-30
-$10.33M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
34.44%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $36.83M | -$24K | $0 |
| Operating Expenses | $13.93M | $13.57M | $7.88M | $10.69M |
| Net Income | -$13.05M | $24.13M | -$7.13M | -$8.69M |
| Net Profit Margin | -- | 65.51% | 29.74K% | -- |
| Earnings Per Share | $-1.05 | $1.65 | $-0.58 | $-1.08 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$13.05M | $24.13M | -$7.13M | -$10.33M |
| Effective Tax Rate | -- | -- | 34.44% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.